Rapamycin suppresses small bowel adenocarcinoma HUTU 80 cells proliferation by inhibiting hypoxia-inducible factor-1α mediated metabolic reprogramming

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-8)

Tables (1-1)

Sum=0

Sep 15, 2025 (publication date) through Sep 15, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Sep 15, 2025; 17(9): 109378
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109378

Table 1 Primer sequences used in this study

HIF-1α: Hypoxia-inducible factor-1α; F: Forward; R: Reverse.

Citation: Pu BP, Wang PH, Guo KK, Liu C, Chen SR, Li XM, Chen SM, Zeng XZ, Gao C. Rapamycin suppresses small bowel adenocarcinoma HUTU 80 cells proliferation by inhibiting hypoxia-inducible factor-1α mediated metabolic reprogramming. World J Gastrointest Oncol 2025; 17(9): 109378
URL: https://www.wjgnet.com/1948-5204/full/v17/i9/109378.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.109378